These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Intervention in autoimmune disorders: creation of a niche for intravenous gamma-globulin therapy. Gelfand EW Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S1-6. PubMed ID: 2477182 [No Abstract] [Full Text] [Related]
9. Clinical use of intravenous gamma-globulin. Barandun S; Morell A; Skvaril F Bibl Haematol; 1980; (46):170-4. PubMed ID: 6155121 [No Abstract] [Full Text] [Related]
10. The current status of intravenous gamma-globulin use in neonates. Gonzalez LA; Hill HR Pediatr Infect Dis J; 1989 May; 8(5):315-22. PubMed ID: 2471136 [No Abstract] [Full Text] [Related]
15. Forms of gamma globulin for intravenous use. South MA Cutis; 1978 Nov; 22(5):554, 566, 636. PubMed ID: 83222 [No Abstract] [Full Text] [Related]
16. Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin. Masuho Y; Tomibe K; Watanabe T; Fukumoto Y Vox Sang; 1977; 32(5):290-5. PubMed ID: 67714 [TBL] [Abstract][Full Text] [Related]
17. [Measurement of the anti-complementary activity of gamma-globulin preparations for intravenous administration]. Malgras J; Hauptmann G; Zorn JJ; Waitz R Rev Fr Transfus; 1970 Jun; 13(2):173-80. PubMed ID: 4100946 [No Abstract] [Full Text] [Related]